Adjuvants, Immunologic
Adolescent
Adult
Aged
Combined Modality Therapy
Disease-Free Survival
Female
Humans
Immunotherapy, Adoptive
Interleukin-2
Lymphatic Metastasis
Lymphocytes, Tumor-Infiltrating
Male
Melanoma
Middle Aged
Survival Rate
T-Lymphocytes
